Renaissance Capital logo

Perspectum Group Filed Terms, Nasdaq: SCAN

Provides a portfolio of medical imaging software.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

We are a leading commercial-stage precision health company focused on democratizing high-quality care globally through the use of our proprietary digital technologies that enable healthcare providers to provide better care for patients. Our software products combine expertise in image formation, magnetic resonance (MR) image analysis and artificial intelligence (AI) to support healthcare provider diagnosis, treatment decision-making and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Our products have the potential to transform clinical management for millions of adult and pediatric patients worldwide by enabling more cost-effective clinical care pathways that support early detection, diagnosis and prognosis, while minimizing the need for expensive, high-risk invasive diagnostic procedures and supporting the targeted use of therapeutics. Our product portfolio comprises cloud-based AI-driven software that utilizes medical images to provide better decision support for the diagnosis, stratification and monitoring of patients with chronic metabolic diseases -- especially liver diseases, multi-organ pathologies, cancer and other conditions that are poorly served by existing diagnostic modalities.
more less
IPO News for Perspectum Group
more
IPO Data
IPO File Date 06/25/2021
Offer Price
Price Range $15.00 - $17.00
Offer Shares (mm) 4.7
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $15.00 - $17.00
Offer Shares (mm) 4.7
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Oxfordshire, United Kingdom
Founded 2012
Employees 192
Website www.perspectum.com